Ledger Run, a leading provider of clinical trial technology services that optimize workflows, announces the acquisition of Assentia, LLC. Ledger Run and its partner Blue Star Innovation Partners (“BSIP”), a growth-focused investment firm founded by serial entrepreneurs Rob Wechsler and Dan Wechsler, acquired Assentia to enhance Ledger Run’s professional services and complement the company’s ClinRun platform, which enables engagement between sponsors, sites, and CROs. Assentia is a tech-enabled pharmaceutical services provider that has scaled rapidly since its launch, with a growing customer base of pharmaceutical, biotech, and clinical research organization clients that utilize Assentia’s market-leading, global clinical trial agreement negotiation capabilities.
Read the full article: Ledger Run Announces Acquisition of Assentia, a Global Pharmaceutical Solutions Provider //
Source: https://www.accesswire.com/934627/ledger-run-announces-acquisition-of-assentia-a-global-pharmaceutical-solutions-provider